Short Term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Multi-cancer early detection tests are precipitating a re-examination of potential short-term endpoints for cancer screening trials. A reduction in advanced stage incidence is a prime candidate, and stage-shift models that substitute early-stage for late-stage survival have been used to predict mort...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, Lukas, Gogebakan, Kemal Caglar, Menon, Usha, Gulati, Roman, Weiss, Noel S, Etzioni, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335323/
https://www.ncbi.nlm.nih.gov/pubmed/37259797
http://dx.doi.org/10.1158/1055-9965.EPI-22-1307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335323/
https://www.ncbi.nlm.nih.gov/pubmed/37259797
http://dx.doi.org/10.1158/1055-9965.EPI-22-1307

Ejemplares similares